• Condensate Coronas and Cellular Cargo Transfer

  2026-11-10

  A recent study describes rare nanoparticle–cell condensate hybrids that carry intact proteins and RNAs between cells. Its strongest evidence links particle architecture, endosomal behavior, molecular composition and reporter activity, while important questions remain about event frequency, cargo heterogeneity and how broadly the mechanism applies.

• How Condensate Coronas Transfer Biomolecules

  2026-11-10

  A Nature Materials study describes a rare cell-mediated transformation in which internalized synthetic nanoparticles acquire condensate-like biological coronas, are re-exported, and transfer proteins and RNAs to recipient cells. The evidence connects corona composition, endosomal remodeling, intracellular release, and reporter-based functional transfer, while leaving important questions about event frequency, single-particle heterogeneity, tissue behavior, and quantitative delivery performance unresolved.

• How Condensate Coronas Transfer RNA

  2026-11-09

  A mechanistic editorial on how rare nanoparticle–condensate hybrids acquire biomolecules, move between cells, and gain intracellular access, with emphasis on the evidence, causal limits, and applicability boundaries.

• How Condensate Coronas Enable RNA Transfer

  2026-11-09

  A literature-focused analysis of how a rare class of nanoparticle–cell hybrids acquires condensate-like biomolecular cargo, survives extracellular transit, and releases functional proteins and RNAs after uptake by another cell.

• How Condensate Coronas Enable RNA Transfer

  2026-11-08

  A published study describes a rare nanoparticle-associated route for moving intact proteins and RNAs between cells, while leaving important questions about event frequency, cargo function, and biological generality unresolved.

• How Condensate Coronas Transfer RNA

  2026-11-07

  A Nature Materials study identifies rare nanoparticle–cell hybrids in which a cell-derived biomolecular condensate forms around an internalized particle, is exported, and later releases proteins and RNAs inside recipient cells. The findings distinguish these complexes from conventional extracellular vesicles while leaving important questions about frequency, molecular origin, cargo organization, and generalizability unresolved.

• What Rare Nanoparticle Complexes Actually Show

  2026-11-06

  A recent study describes a rare class of cell-derived condensate–nanoparticle hybrids that can transport intact proteins and RNAs between cells. Its strongest contribution is mechanistic: it links particle-associated condensate remodeling to intracellular release, while leaving frequency, generality and delivery performance unresolved.

• How Condensate Coronas Enable RNA Transfer

  2026-11-06

  A rare subset of internalized nanoparticles can acquire cell-derived biomolecular condensates, leave the cell, and deliver intact proteins and RNAs to recipient-cell compartments. The evidence supports a mechanism involving condensate formation, endosomal fluidization, and selective intracellular release, while leaving important questions about molecular recognition, frequency, and generalizability unresolved.

• How Condensate Coronas Enable RNA Transfer

  2026-11-05

  A recent study describes rare nanoparticle–cell hybrids in which a cell-derived condensate corona appears to organize the transfer of intact proteins and RNAs between cells. The strongest evidence links endosomal condensate detachment, non-endolysosomal access and reporter activity, while the physiological prevalence and generality of the mechanism remain uncertain.

• How Condensate Coronas Enable RNA Transfer

  2026-11-05

  A mechanistic analysis of how rare nanoparticle–condensate complexes acquire, stabilize and transfer intact proteins and RNAs between cells, with emphasis on endosomal release, functional readouts and the limits of current evidence.

• What Rare Nanoparticle Complexes Reveal About RNA Transfer

  2026-11-04

  A recent study describes a rare class of cell-derived condensate–nanoparticle complexes that can move proteins and RNA between cells. Its findings support a mechanistic model involving condensate acquisition, endosomal separation and intracellular access, while leaving major questions about frequency, causality and generalizability unresolved.

• How Condensate Coronas Transfer RNA Between Cells

  2026-11-04

  A Nature Materials study identifies rare nanoparticle–condensate hybrids that carry intact proteins and RNAs between cells. Its evidence links corona composition, endosomal separation and reporter-based functional transfer, while leaving important questions about particle heterogeneity, biological generality and in vivo relevance.

• When Condensate Coronas Redirect Nanoparticles

  2026-11-03

  Can a nanoparticle acquire a cell-derived biomolecular layer that changes its intracellular fate? The study presents evidence that a rare hybrid particle state can separate from endosomal compartments and redistribute proteins and RNA-associated material inside cells, while differing molecularly from extracellular vesicles.

• Context Changes What p53 mRNA Results Mean

  2026-11-03

  Results involving p53-encoding mRNA cannot be interpreted apart from the carrier, tumor model, comparator, immune setting and readout. A 2025 review supports a biologically plausible but formulation-specific interpretation of lipid nanoparticle delivery, while reported p53 findings remain indirect, mainly preclinical and insufficient to validate any particular material.

• Condensate Coronas and Cellular Cargo Transfer

  2026-11-02

  A mechanistic cell-biology study describes how a rare nanoparticle subpopulation acquires a cell-derived condensate corona, is re-exported, and can separate from its core after endosomal uptake. Comparative molecular analyses distinguish these hybrid complexes from extracellular vesicles and support a recognition-dependent route for intracellular redistribution of proteins and RNA.

8181 records 1/546 page Next 12345 下5页 Last page